Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways (Q35091428)

6 August 2017

1 reference

title

Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways (English)

1 reference

6 August 2017

1 reference

Rieux-Laucat F

1

1 reference

PubMed ID

12655301

6 August 2017

Le Deist F

series ordinal

2

1 reference

PubMed ID

12655301

6 August 2017

Fischer A

series ordinal

3

1 reference

6 August 2017

1 January 2003

1 reference

Cell Death & Differentiation

6 August 2017

1 reference

6 August 2017

10

1 reference

6 August 2017

1

1 reference

6 August 2017

124-133

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401190

6 August 2017

0 references

cites work

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

The TNF and TNF receptor superfamilies: integrating mammalian biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Molecular ordering of the initial signaling events of CD95.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Daxx, a novel Fas-binding protein that activates JNK and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Regulation of lymphocyte proliferation and death by FLIP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Chronic lymphadenopathy simulating malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

1 reference

7 January 2021

Fas and Fas ligand: lpr and gld mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Apoptosis by death factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Clinical, immunological, and pathological consequences of Fas-deficient conditions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Diffuse large B-cell non-Hodgkin's lymphoma in a patient with autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Pathological findings in human autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis--CT and US features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Cytomegalovirus infection in infants with autoimmune lymphoproliferative syndrome (ALPS)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Dyserythropoiesis associated with a Fas-deficient condition in childhood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Characterization of lymphoproliferation induced by interactions between Ipr and gld genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Caspase-10 is an initiator caspase in death receptor signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Enhanced CD4+ T cell proliferation and Th2 cytokine production in DR6-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Impaired c-Jun amino terminal kinase activity and T cell differentiation in death receptor 6-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

DR3 regulates negative selection during thymocyte development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401190

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4401190

1 reference

6 August 2017

1 reference

PubMed ID

12655301